CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Almac Group Appoints Three Vice Presidents

Almac Group, the global contract development and manufacturing organisation, has announced the appointment of three new Vice Presidents within its Pharma Servic...
Continue Reading →
News

Almac Group Appoints David Taylor as Head of Manufacturing Operations

David Taylor joined the Almac Group in November 2017 as Head of Manufacturing, Almac Sciences.  He is tasked with the overall accountability for small molecul...
Continue Reading →
News

Almac Discovery to share latest developments in first-in-class DUB inhibitors at the at 8th Proteasome and Autophagy Congress

Almac Discovery, a biopharmaceutical company with a key research focus in the area of deubiquitylating enzyme therapeutic discovery, has had its work recognised ...
Continue Reading →
News

Almac Diagnostics Validates Illumina TruSight® Tumor 170 Cancer Mutation Panel for Prospective Testing in Clinical Trials

   CLIA compliant assay, for clinical trial use, including US and Europe Validation performance specifications for review on Almac Diagnostics...
Continue Reading →
Uncategorised

Almac Group Expands with Opening of £20 million Cold Chain Facility

Craigavon, N.I., 28 February 2018 – Almac Group, the global contract pharmaceutical development and manufacturing organisation, today announced the completion of a £...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026